The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Initial results of MC200710 investigating therapeutic vaccine (PDS0101) alone or with pembrolizumab prior to surgery or radiation therapy for locally advanced HPV associated oropharyngeal carcinoma, a phase 2 window of opportunity trial.
 
David Routman
Employment - Mayo Clinic; Mayo Clinic (I)
Research Funding - PDS Biotechnology
Patents, Royalties, Other Intellectual Property - DNA methylation patterns related to oropharyngeal carcinoma, licensed to Exact Sciences
 
Katharine Price
Consulting or Advisory Role - PDS Biotechnology
(OPTIONAL) Uncompensated Relationships - InSitu Therapeutics; InSitu Therapeutics
 
Erik Asmus
No Relationships to Disclose
 
Nathan Foster
No Relationships to Disclose
 
Eric Moore
No Relationships to Disclose
 
Daniel Price
No Relationships to Disclose
 
Kendall Tasche
No Relationships to Disclose
 
Linda Yin
No Relationships to Disclose
 
Patrick McGarrah
No Relationships to Disclose
 
Harry Fuentes Bayne
No Relationships to Disclose
 
Courtney Erskine
No Relationships to Disclose
 
Kathleen Bartemes
No Relationships to Disclose
 
Ronen Stoff
Consulting or Advisory Role - Pangaea Biotech
Speakers' Bureau - Merck Serono; MSD Oncology
 
Scott Lester
Employment - Mayo Clinic
Patents, Royalties, Other Intellectual Property - Empyrean Medical; royalties related to development of advanced radiation device; Empyrean Medical; royalties related to development of advanced radiation device; Empyrean Medical; royalties related to development of advanced radiation device
 
Daniel Ma
No Relationships to Disclose
 
Michelle Neben-Wittich
No Relationships to Disclose
 
Jessica Wilson
No Relationships to Disclose
 
Matthew Block
Research Funding - Alkermes (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Marker, Inc. (Inst); Merck (Inst); nference (Inst); Perspective Therapeutics (Inst); Pharmacyclics (Inst); Regeneron (Inst); Sorrento Therapeutics (Inst); TILT Biotherapeutics (Inst); Transgene (Inst); Viewpoint Molecular Targeting (Inst)
Patents, Royalties, Other Intellectual Property - Combinations of Dendritic Cell-Based Vaccines and Checkpoint Inhibitors, patent pending (Inst); Dendritic Cell-Based Vaccines and Uses Thereof, patent pending (Inst)
(OPTIONAL) Uncompensated Relationships - Sorrento Therapeutics; TILT Biotherapeutics; Viewpoint Molecular Targeting
 
Kathryn Van Abel
Patents, Royalties, Other Intellectual Property - Exact Sciences (Inst); Transonal Surgical Devices
Travel, Accommodations, Expenses - Intuitive Surgical
 
Ashish Chintakuntlawar
No Relationships to Disclose